Get started
Author

S. Wu

Observed name: S. K. Wu
OpenAlex ID: A5126460844
Abstract PS2-12-07: Metabolic and immune reprogramming via SCD1 inhibition enhances chemo-immunotherapy response in TNBC
2026 · P. P. Advani, S. K. Deshmukh, et al. · Clinical Cancer Research · 1
31P ERBB2 Mutations in Metastatic Breast Cancer: Histology-Specific Molecular, Immune, and Clonal Features
2026 · G. Nader Marta, S.K. Deshmukh, et al. · ESMO Open
PDF
Abstract PD9-07: The Genomic, Transcriptomic, and Immune Hallmarks of Metastatic Lobular Breast Cancer
2026 · G. Nader-Marta, S. Kumar Deshmukh, et al. · Clinical Cancer Research
Abstract PS4-05-05: EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition
2026 · D. J. Wiisniewski, D. J. Voeller, et al. · Clinical Cancer Research
Abstract PS3-12-06: Immune microenvironment and survival differences among Hispanic and African American breast cancer cases by biopsy site
2026 · R. Hsu, S. Deshmukh, et al. · Clinical Cancer Research
Abstract PS4-01-13: Comparative efficacy of antibody drug conjugates (ADCs) in male versus female breast cancer across the spectrum of HER2 expression
2026 · D. Trapani, S. Deshmukh, et al. · Clinical Cancer Research
Abstract PS2-09-08: Tertiary lymphoid structure (TLS)-related gene expression and outcomes in HER2-Positive (HER2+) breast cancer (BC) in the Real-World Database
2026 · S. Chumsri, S. Deshmukh, et al. · Clinical Cancer Research
Abstract PS2-08-02: Comprehensive Characterization of PTEN loss by IHC and PTEN alteration by NGS in Metastatic HR-Positive, HER2-Negative Breast Cancer-- An Exploratory Analysis of Biomarker Concordance and Co-Occurrence
2026 · R. L. Mahtani, S. C. Smith, et al. · Clinical Cancer Research
Abstract PS2-08-14: Chemokine signatures improve PD-L1-based prediction of pembrolizumab response in triple-negative breast cancer
2026 · S. Gandhi, S. Deshmukh, et al. · Clinical Cancer Research
Abstract PS2-10-25: Combined T and B cell signatures as prognostic biomarkers in triple-negative breast cancer (TNBC)
2026 · S. Gandhi, S. Kumar Deshmukh, et al. · Clinical Cancer Research
Abstract PS2-09-19: Tonsl, an immortalizing oncogene on chr.8q24.3 amplicon, confers intrinsic resistance to cdk4/6 inhibitors in breast cancer
2026 · H. Nakshatri, A. S. Khatpe, et al. · Clinical Cancer Research
Abstract PS2-08-04: Site specific Genomic and Immune Landscapes Underpinning in metastatic Male Breast Cancer
2026 · D. Trapani, S. Deshmukh, et al. · Clinical Cancer Research
Works count: 12
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type